|
Implantable Access Device
Client:Pfizer Inc., Valley Labs Division, Strategic Innovation Group, Pfresh Tech Think Tank. For dialysis procedures, an implantable access device for allowing repeat access to a site within the body of a patient, which allows for the passage of fluids, filaments or therapeutic agents. US Patent #5,741,228 “Implantable access device”, 1998 Assignee: Horizon Medical, Atlanta, GA. |